| Crowe Mikhailenko | 80.0 | 5 | 1 |
| Steve Madsen | 66.4 | 3 | 1 |
| KPMG | 56.8 | 2 | 1 |
| Madsen and Company | 56.8 | 2 | 1 |
| Deloitte | 53.9 | 4 | 0 |
| McDermott Will & Emery | 53.9 | 4 | 0 |
| PricewaterhouseCoopers | 46.4 | 3 | 0 |
| tax planning | 40.0 | 0 | 3 |
| International tax planning | 40.0 | 0 | 3 |
| International Tax Planning: Transfer Pricing and Transactions Between Foreign Entities | 40.0 | 0 | 3 |
| Estimation of international tax planning impact on corporate tax gap in the Czech Republic | 40.0 | 0 | 3 |
| Maven Cost Segregation: Tax Advisors | 40.0 | 0 | 3 |
| Sean Graham | 40.0 | 0 | 3 |
| GEOTAX | 40.0 | 0 | 3 |
| Wolters Kluwer | 36.8 | 2 | 0 |
| Ernst & Young | 36.8 | 2 | 0 |
| Forvis Mazars | 36.8 | 2 | 0 |
| Cushman & Wakefield | 36.8 | 2 | 0 |
| Skadden, Arps, Slate, Meagher & Flom | 36.8 | 2 | 0 |
| Jones Lang LaSalle | 36.8 | 2 | 0 |
| Latham & Watkins | 36.8 | 2 | 0 |
| Wolters Kluwer Deutschland | 36.8 | 2 | 0 |
| Sidley Austin | 36.8 | 2 | 0 |
| Alston & Bird | 36.8 | 2 | 0 |
| Baker Botts | 36.8 | 2 | 0 |
| Davis Polk & Wardwell | 36.8 | 2 | 0 |
| Fried, Frank, Harris, Shriver & Jacobson | 36.8 | 2 | 0 |
| Greenberg Traurig | 36.8 | 2 | 0 |
| Holland & Knight | 36.8 | 2 | 0 |
| Holman Fenwick Willan | 36.8 | 2 | 0 |
| Mayer Brown | 36.8 | 2 | 0 |
| McCarter & English | 36.8 | 2 | 0 |
| Deloitte Deutschland | 36.8 | 2 | 0 |
| tax advisor | 31.7 | 0 | 2 |
| International Tax Journal | 31.7 | 0 | 2 |
| Steuerberater | 31.7 | 0 | 2 |
| Land and Buildings Transaction Tax | 31.7 | 0 | 2 |
| Corporate tax planning and thin-capitalization rules: evidence from a quasi-experiment | 31.7 | 0 | 2 |
| In praise of tax havens: International tax planning and foreign direct investment | 31.7 | 0 | 2 |
| Land Transaction Tax | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2019 | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2018 | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2020 | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2017 | 31.7 | 0 | 2 |
| The International Tax Compliance (Client Notification) Regulations 2016 | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2015 | 31.7 | 0 | 2 |
| The International Tax Compliance Regulations 2015 | 31.7 | 0 | 2 |
| The International Tax Compliance (Crown Dependencies and Gibraltar) (Amendment) Regulations 2015 | 31.7 | 0 | 2 |
| The International Tax Compliance (United States of America) Regulations 2014 | 31.7 | 0 | 2 |
| The International Tax Compliance (Crown Dependencies and Gibraltar) Regulations 2014 | 31.7 | 0 | 2 |
| The International Tax Compliance (United States of America) Regulations 2013 | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) (No. 2) (EU Exit) Regulations 2020 | 31.7 | 0 | 2 |
| Does Credit-card Information Reporting Improve Small-business Tax Compliance? | 31.7 | 0 | 2 |
| The Impact of Corporate Taxes on Firm Innovation: Evidence from the Corporate Tax Collection Reform in China | 31.7 | 0 | 2 |
| The Structure of State Corporate Taxation and its Impact on State Tax Revenues and Economic Activity | 31.7 | 0 | 2 |
| The Changing Role of Auditors in Corporate Tax Planning | 31.7 | 0 | 2 |
| Why Is There Corporate Taxation In a Small Open Economy? The Role of Transfer Pricing and Income Shifting | 31.7 | 0 | 2 |
| global minimum corporate tax rate | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2021 | 31.7 | 0 | 2 |
| State Tax Planning Can Reduce Cost of Expanding Gaming Operations Outside Nevada | 31.7 | 0 | 2 |
| Foreign Accounts Tax Compliance Act and American Leadership in the Campaign against International Tax Evasion: Revolution or False Dawn? | 31.7 | 0 | 2 |
| Loss Aversion, Transaction Costs, or Audit Trigger? Learning About Corporate Tax Compliance from a Policy Experiment with Withholding Regime | 31.7 | 0 | 2 |
| Determinants of Business Tax Compliance | 31.7 | 0 | 2 |
| An Experimental Evaluation of Notification Strategies to Increase Property Tax Compliance: Free-Riding in the City of Brotherly Love | 31.7 | 0 | 2 |
| Wealth Transfer Tax Planning for 2013 and Beyond | 31.7 | 0 | 2 |
| Does credit-card information reporting improve small-business tax compliance? | 31.7 | 0 | 2 |
| income shifting | 31.7 | 0 | 2 |
| Small business tax compliance burden : what can be done to level the playing field. | 31.7 | 0 | 2 |
| Back to Source - From International Corporate Tax Neutrality to Efficient Investment Policy and its Implication on the Desirable International Tax Policy | 31.7 | 0 | 2 |
| When do firms use one set of books in an international tax compliance game? | 31.7 | 0 | 2 |
| How does FDI react to corporate taxation? | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2022 | 31.7 | 0 | 2 |
| Third-Party Information,Tax Compliance and International Tax Competition | 31.7 | 0 | 2 |
| Capital Market Opening-up and Corporate Tax Compliance: Evidence from Mainland-Hong Kong Stock Connect | 31.7 | 0 | 2 |
| Related Finance Company and Corporate Tax Planning | 31.7 | 0 | 2 |
| Economic Fluctuations,Tax Efforts and Corporate Tax Compliance | 31.7 | 0 | 2 |
| Grafting System:Western Tax System and the Division of State Tax and Local Tax in the Qing Dynasty | 31.7 | 0 | 2 |
| The Transfer Pricing Rules of Intangible Properties from the Perspective of International Tax Division | 31.7 | 0 | 2 |
| Does going public affect corporate tax planning behavior? | 31.7 | 0 | 2 |
| International Tax Planning of Three Ways Cross-border Income Tax on the ’Go Global’ Enterprises——An Observe on ’Belt and Road’ Initiative along the Country（Region） | 31.7 | 0 | 2 |
| The Tax Planning Analysis of Tangible Movables Lease Service Enterprises after Modified Business Tax VAT | 31.7 | 0 | 2 |
| The Value-added Tax Reform and Corporate Tax Compliance | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2023 | 31.7 | 0 | 2 |
| International Tax Planning: The Foreign Affiliate Surplus Reclassification Rule | 31.7 | 0 | 2 |
| Corporate tax planning and corporate tax disclosure | 31.7 | 0 | 2 |
| CEO Severance Pay and Corporate Tax Planning | 31.7 | 0 | 2 |
| State and provincial corporate tax planning: income shifting and sales apportionment factor management | 31.7 | 0 | 2 |
| Legal Environment and Corporate Tax Avoidance: Evidence from State Tax Codes | 31.7 | 0 | 2 |
| LEGAL REGULATION OF NEW INSTITUTIONS OF INTERNATIONAL TAX LAW: TRANSFER PRICING AND TAXATION OF CONTROLLED FOREIGN COMPANIES | 31.7 | 0 | 2 |
| International Tax Planning: The Stop-Loss Rules and Corporate Reorganizations—Interpretive Challenges | 31.7 | 0 | 2 |
| Corporate Tax Planning and Political Costs: Peer Effects of Foreign Institutional Ownership | 31.7 | 0 | 2 |
| The corporate tax planning and financial performance of systemically important banks in Nigeria | 31.7 | 0 | 2 |
| Improvement plan of Property Tax Payment System of Trust Property on Current Local Tax Act | 31.7 | 0 | 2 |
| A Study on the Type of Acquisition based on the Local Tax Law of the Gratuitous Transfer of Maintenance Infrastructure Subject to Usage Rescission and the Standard Tax Rate of the Acquisition Tax | 31.7 | 0 | 2 |
| A Study on the Interest for Construction Capital in the Local Tax Law and the Tax Bases of Acquisition Tax - Supreme Court Decision 2014Du46935 Sentenced March 29, 2018 - | 31.7 | 0 | 2 |
| Strategic reactions in corporate tax planning | 31.7 | 0 | 2 |
| Corporate Tax Planning Practice: A Bourdiesian’s Perspective | 31.7 | 0 | 2 |
| Consumer Responses to Corporate Tax Planning | 31.7 | 0 | 2 |
| How does quasi-indexer ownership affect corporate tax planning? | 31.7 | 0 | 2 |
| Corporate tax compliance: Is a change towards trust-based tax strategies justified? | 31.7 | 0 | 2 |
| The Effect of Taxpayer Characteristics on the Tax Consciousness and Tax Compliance Action of Local Tax | 31.7 | 0 | 2 |
| 'Home Sweet Home' versus International Tax Planning: Where Do Multinational Firms Hold Their U.S. Trademarks? | 31.7 | 0 | 2 |
| Expected Economic Growth and Corporate Tax Planning | 31.7 | 0 | 2 |
| Transfer Pricing Abuse: the Ghanaian Perspective and the Role of the Accountant in Tax Compliance | 31.7 | 0 | 2 |
| Pinson on revenue law: comprising income tax, capital gains tax, development land tax, corporation tax, capital transfer tax, value added tax, stamp duties, tax planning | 31.7 | 0 | 2 |
| Strategic business tax planning | 31.7 | 0 | 2 |
| Property Tax Planning | 31.7 | 0 | 2 |
| The German Property Tax as a Local Business Tax | 31.7 | 0 | 2 |
| Fintua | 31.7 | 0 | 2 |
| The International Tax Compliance (Amendment) Regulations 2025 | 31.7 | 0 | 2 |
| Tax Relief Helpers | 31.7 | 0 | 2 |
| Gökay Gül | 31.7 | 0 | 2 |
| Public good provision and property tax compliance: Evidence from a natural experiment | 31.7 | 0 | 2 |
| Deloitte Football Money League | 23.2 | 1 | 0 |
| Arthur Andersen | 23.2 | 1 | 0 |
| Alvarez and Marsal | 23.2 | 1 | 0 |
| Q735991 | 23.2 | 1 | 0 |
| Baker McKenzie | 23.2 | 1 | 0 |
| Crowe Global | 23.2 | 1 | 0 |
| Paul Hastings | 23.2 | 1 | 0 |
| CBRE Group | 23.2 | 1 | 0 |
| Freshfields Bruckhaus Deringer | 23.2 | 1 | 0 |
| DLA Piper | 23.2 | 1 | 0 |
| Entrepreneur of the Year | 23.2 | 1 | 0 |
| Baker Tilly | 23.2 | 1 | 0 |
| Kirkland & Ellis | 23.2 | 1 | 0 |
| Lenz & Staehelin | 23.2 | 1 | 0 |
| Moss Adams | 23.2 | 1 | 0 |
| PricewaterhouseCoopers (Deutschland) | 23.2 | 1 | 0 |
| 1211 Avenue of the Americas | 23.2 | 1 | 0 |
| Manatt, Phelps & Phillips | 23.2 | 1 | 0 |
| Addleshaw Goddard | 23.2 | 1 | 0 |
| BDO Seidman | 23.2 | 1 | 0 |
| FORVIS | 23.2 | 1 | 0 |
| Baker Tilly Virchow Krause, LLP | 23.2 | 1 | 0 |
| Ballard Spahr | 23.2 | 1 | 0 |
| Bob Tata | 23.2 | 1 | 0 |
| CT | 23.2 | 1 | 0 |
| Cadwalader, Wickersham & Taft | 23.2 | 1 | 0 |
| Cherry Bekaert LLP | 23.2 | 1 | 0 |
| CliftonLarsonAllen | 23.2 | 1 | 0 |
| FTI Consulting | 23.2 | 1 | 0 |
| Goodwin | 23.2 | 1 | 0 |
| Grant Thornton LLP | 23.2 | 1 | 0 |
| Hunton Andrews Kurth | 23.2 | 1 | 0 |
| K&L Gates | 23.2 | 1 | 0 |
| Lowenstein Sandler | 23.2 | 1 | 0 |
| RSM US | 23.2 | 1 | 0 |
| Morrison & Foerster | 23.2 | 1 | 0 |
| Philip Perry | 23.2 | 1 | 0 |
| Plante Moran | 23.2 | 1 | 0 |
| Russell-Cooke Solicitors | 23.2 | 1 | 0 |
| Weil, Gotshal & Manges | 23.2 | 1 | 0 |
| Willkie Farr & Gallagher | 23.2 | 1 | 0 |
| PricewaterhouseCoopers Japan LLC | 23.2 | 1 | 0 |
| Deloitte Tohmatsu | 23.2 | 1 | 0 |
| Q11375641 | 23.2 | 1 | 0 |
| KPMG Azsa LLC | 23.2 | 1 | 0 |
| Deloitte Touche Tohmatsu LLC | 23.2 | 1 | 0 |
| Dentons | 23.2 | 1 | 0 |
| TurboTax | 23.2 | 1 | 0 |
| Acta Neurologica Taiwanica | 23.2 | 1 | 0 |
| Bennett Thrasher LLP | 23.2 | 1 | 0 |
| Hoover's Inc. | 23.2 | 1 | 0 |
| Mitchell & Titus | 23.2 | 1 | 0 |
| National Equality Standard | 23.2 | 1 | 0 |
| Q17192764 | 23.2 | 1 | 0 |
| Chip Babcock | 23.2 | 1 | 0 |
| CohnReznick | 23.2 | 1 | 0 |
| Deloitte Netherlands | 23.2 | 1 | 0 |
| EY Sweden | 23.2 | 1 | 0 |
| Ryan LLC | 23.2 | 1 | 0 |
| FTI Consulting EMEA | 23.2 | 1 | 0 |
| FTI Consulting LATAM | 23.2 | 1 | 0 |
| FTI Consulting APAC | 23.2 | 1 | 0 |
| Citrin Cooperman | 23.2 | 1 | 0 |
| Anchin Block & Anchin | 23.2 | 1 | 0 |
| Gowling WLG | 23.2 | 1 | 0 |
| International journal of women's dermatology | 23.2 | 1 | 0 |
| Wolters Kluwer Health | 23.2 | 1 | 0 |
| Ernst and Young Foundation | 23.2 | 1 | 0 |
| Monitor-Deloitte | 23.2 | 1 | 0 |
| PricewaterhouseCoopers (Canada) | 23.2 | 1 | 0 |
| PricewaterhouseCoopers (Sweden) | 23.2 | 1 | 0 |
| PricewaterhouseCoopers (Norway) | 23.2 | 1 | 0 |
| PricewaterhouseCoopers (South Korea) | 23.2 | 1 | 0 |
| Lejb Fogelman | 23.2 | 1 | 0 |
| Major League Soccer | 20.0 | 0 | 1 |
| Salt Lake City | 20.0 | 0 | 1 |
| Josef Schnusenberg | 20.0 | 0 | 1 |
| Norbert Wollheim | 20.0 | 0 | 1 |
| Zinsschranke | 20.0 | 0 | 1 |
| Sergei Magnitsky | 20.0 | 0 | 1 |
| Millones | 20.0 | 0 | 1 |
| Purchase price allocation | 20.0 | 0 | 1 |
| tax avoidance | 20.0 | 0 | 1 |
| Foreign Account Tax Compliance Act | 20.0 | 0 | 1 |
| window tax | 20.0 | 0 | 1 |
| Corporate tax in the Netherlands | 20.0 | 0 | 1 |
| dividend imputation | 20.0 | 0 | 1 |
| property tax | 20.0 | 0 | 1 |
| Tax Justice Network | 20.0 | 0 | 1 |
| corporate tax | 20.0 | 0 | 1 |
| transfer price | 20.0 | 0 | 1 |
| Bernard Broermann | 20.0 | 0 | 1 |
| corporate tax management | 20.0 | 0 | 1 |
| rates | 20.0 | 0 | 1 |
| Precision Manuals Development Group | 20.0 | 0 | 1 |
| Tobin tax | 20.0 | 0 | 1 |
| beer tax | 20.0 | 0 | 1 |
| Blockout | 20.0 | 0 | 1 |
| United States Naval Special Warfare Development Group | 20.0 | 0 | 1 |
| DICT | 20.0 | 0 | 1 |
| Horst Walter Endriss | 20.0 | 0 | 1 |
| Carl-Christian Freidank | 20.0 | 0 | 1 |
| Carl Neubronner | 20.0 | 0 | 1 |
| California Proposition 13 | 20.0 | 0 | 1 |
| Double Irish arrangement | 20.0 | 0 | 1 |
| Hans-Georg Graichen | 20.0 | 0 | 1 |
| United Nations Sustainable Development Group | 20.0 | 0 | 1 |
| Dieter Burr | 20.0 | 0 | 1 |
| Dietmar Wellisch | 20.0 | 0 | 1 |
| local tax in Germany | 20.0 | 0 | 1 |
| financial transaction tax | 20.0 | 0 | 1 |
| inheritance tax in Germany | 20.0 | 0 | 1 |
| tax compliance | 20.0 | 0 | 1 |
| Ernst Féaux de la Croix | 20.0 | 0 | 1 |
| Felix Stilz | 20.0 | 0 | 1 |
| Norbert Winkeljohann | 20.0 | 0 | 1 |
| Michael Josten | 20.0 | 0 | 1 |
| fishery tax | 20.0 | 0 | 1 |
| Reinhard Kapp | 20.0 | 0 | 1 |
| capital transfer tax | 20.0 | 0 | 1 |
| real estate transfer tax | 20.0 | 0 | 1 |
| Frank Reinhardt | 20.0 | 0 | 1 |
| Franz Longin | 20.0 | 0 | 1 |
| Franz Wassermeyer | 20.0 | 0 | 1 |
| Fraunhofer Technology Development Group | 20.0 | 0 | 1 |
| Gerd-Dieter Mirtl | 20.0 | 0 | 1 |
| Josef Schlarmann | 20.0 | 0 | 1 |
| Association of Bavarian Waste Management Companies | 20.0 | 0 | 1 |
| property tax in Germany | 20.0 | 0 | 1 |
| Horst Vinken | 20.0 | 0 | 1 |
| Hans-Michael Wolffgang | 20.0 | 0 | 1 |
| Hans-Ulrich Twiehaus | 20.0 | 0 | 1 |
| Hans Vehrenberg | 20.0 | 0 | 1 |
| Helmut Bein | 20.0 | 0 | 1 |
| Helmut von Bockelberg | 20.0 | 0 | 1 |
| Helmuth Josseck | 20.0 | 0 | 1 |
| Hermann Böhacker | 20.0 | 0 | 1 |
| Hubert Rauch | 20.0 | 0 | 1 |
| Roman Leitner Senior | 20.0 | 0 | 1 |
| International Tax Review | 20.0 | 0 | 1 |
| International tax law (Germany) | 20.0 | 0 | 1 |
| Ursula Peters | 20.0 | 0 | 1 |
| Wilhelm Haarmann | 20.0 | 0 | 1 |
| Karl-Heinz Forster | 20.0 | 0 | 1 |
| Klaus-Peter Naumann | 20.0 | 0 | 1 |
| Landwirtschaftlicher Buchführungsverband | 20.0 | 0 | 1 |
| indirect tax | 20.0 | 0 | 1 |
| Kurt Lentsch | 20.0 | 0 | 1 |
| corporate tax in Germany | 20.0 | 0 | 1 |
| Albert J. Rädler | 20.0 | 0 | 1 |
| Andreas Staribacher | 20.0 | 0 | 1 |
| state tax | 20.0 | 0 | 1 |
| mandate | 20.0 | 0 | 1 |
| Marianne Schmidl | 20.0 | 0 | 1 |
| Matthias Witt | 20.0 | 0 | 1 |
| Value added tax (Switzerland) | 20.0 | 0 | 1 |
| Common Consolidated Corporate Tax Base | 20.0 | 0 | 1 |
| Marihuana Tax Act of 1937 | 20.0 | 0 | 1 |
| Siegfried Grotherr | 20.0 | 0 | 1 |
| tax consultant | 20.0 | 0 | 1 |
| hearth tax | 20.0 | 0 | 1 |
| event management company | 20.0 | 0 | 1 |
| Wilfried Stauder | 20.0 | 0 | 1 |
| Wilhelm Deimen | 20.0 | 0 | 1 |
| Alexander Hemmelrath | 20.0 | 0 | 1 |
| Allianz der öffentlichen Wasserwirtschaft | 20.0 | 0 | 1 |
| European Union financial transaction tax | 20.0 | 0 | 1 |
| local tax | 20.0 | 0 | 1 |
| Corporate tax in the United States | 20.0 | 0 | 1 |
| United Kingdom corporation tax | 20.0 | 0 | 1 |
| local tax in France | 20.0 | 0 | 1 |
| Accounting period | 20.0 | 0 | 1 |
| tax compliance software | 20.0 | 0 | 1 |
| Service des impôts des entreprises | 20.0 | 0 | 1 |
| Business tax | 20.0 | 0 | 1 |
| business tax | 20.0 | 0 | 1 |
| Q4035526 | 20.0 | 0 | 1 |
| Miraculix | 20.0 | 0 | 1 |
| State tax service of Ukraine | 20.0 | 0 | 1 |
| Ladakh Ecological Development and Environmental Group | 20.0 | 0 | 1 |
| State Tax Service under the Ministry of the Economy | 20.0 | 0 | 1 |
| Corporate property tax | 20.0 | 0 | 1 |
| tax shelter | 20.0 | 0 | 1 |
| ANGIS | 20.0 | 0 | 1 |
| Appropriate Infrastructure Development Group | 20.0 | 0 | 1 |
| Asia Oceania Tax Consultants' Association | 20.0 | 0 | 1 |
| Automated Payment Transaction tax | 20.0 | 0 | 1 |
| Bank transaction tax | 20.0 | 0 | 1 |
| Spanish Tax Agency | 20.0 | 0 | 1 |
| Bradley-Burns uniform local tax law | 20.0 | 0 | 1 |
| Brain development timelines | 20.0 | 0 | 1 |
| Brick tax | 20.0 | 0 | 1 |
| 2012 California Proposition 39 | 20.0 | 0 | 1 |
| Chief Capability Development Group | 20.0 | 0 | 1 |
| corporate haven | 20.0 | 0 | 1 |
| tax inversion | 20.0 | 0 | 1 |
| Corporation tax in the Republic of Ireland | 20.0 | 0 | 1 |
| Cost segregation study | 20.0 | 0 | 1 |
| Currency transaction tax | 20.0 | 0 | 1 |
| David Hurley | 20.0 | 0 | 1 |
| earnings | 20.0 | 0 | 1 |
| Energy Task Force | 20.0 | 0 | 1 |
| exchange of information | 20.0 | 0 | 1 |
| Face Oculta | 20.0 | 0 | 1 |
| Foreign Investment in Real Property Tax Act | 20.0 | 0 | 1 |
| Formulary apportionment | 20.0 | 0 | 1 |
| Funds transfer pricing | 20.0 | 0 | 1 |
| Generation-skipping transfer tax | 20.0 | 0 | 1 |
| taxation in Iran | 20.0 | 0 | 1 |
| Idaho Property Tax Relief Act of 2006 | 20.0 | 0 | 1 |
| local tax system in Spain | 20.0 | 0 | 1 |
| John Caligari | 20.0 | 0 | 1 |
| KDD Group | 20.0 | 0 | 1 |
| Category:Waste management companies of the United Kingdom | 20.0 | 0 | 1 |
| Category:Waste management companies by country | 20.0 | 0 | 1 |
| Category:Investment management companies of France | 20.0 | 0 | 1 |
| First Liberty Institute | 20.0 | 0 | 1 |
| Liberty Tax Service | 20.0 | 0 | 1 |
| Like-kind exchange | 20.0 | 0 | 1 |
| gabela | 20.0 | 0 | 1 |
| Local Property Tax | 20.0 | 0 | 1 |
| Mansion Tax | 20.0 | 0 | 1 |
| Matt Tripovich | 20.0 | 0 | 1 |
| Ofer Eini | 20.0 | 0 | 1 |
| McClanahan v. Arizona State Tax Comm'n | 20.0 | 0 | 1 |
| Category:United Nations Development Group | 20.0 | 0 | 1 |
| Nonbusiness Energy Property Tax Credit | 20.0 | 0 | 1 |
| North Dakota Office of State Tax Commissioner | 20.0 | 0 | 1 |
| Oregon Ballot Measures 47 (1996) and 50 | 20.0 | 0 | 1 |
| Peter Jones | 20.0 | 0 | 1 |
| Philip Robinson | 20.0 | 0 | 1 |
| Poor rate | 20.0 | 0 | 1 |
| Practical Action | 20.0 | 0 | 1 |
| Property tax in the United States | 20.0 | 0 | 1 |
| Red Feather Development Group | 20.0 | 0 | 1 |
| Research & Experimentation Tax Credit | 20.0 | 0 | 1 |
| SATURN Development Group | 20.0 | 0 | 1 |
| SIMPLE Group | 20.0 | 0 | 1 |
| Sales taxes in the United States | 20.0 | 0 | 1 |
| Sea Pines Company | 20.0 | 0 | 1 |
| State tax levels in the United States | 20.0 | 0 | 1 |
| land tax | 20.0 | 0 | 1 |
| Swarm Development Group | 20.0 | 0 | 1 |
| Swedish financial transaction tax | 20.0 | 0 | 1 |
| Tax Commissioner of New York State | 20.0 | 0 | 1 |
| Tenants in common 1031 exchange | 20.0 | 0 | 1 |
| The Summit Open Source Development Group | 20.0 | 0 | 1 |
| Tim Dunn | 20.0 | 0 | 1 |
| Transactional net margin method | 20.0 | 0 | 1 |
| Transport Development Group | 20.0 | 0 | 1 |
| Tunnels of Armageddon | 20.0 | 0 | 1 |
| U.S.–Israel Joint Economic Development Group | 20.0 | 0 | 1 |
| Volunteers for Economic Growth Alliance | 20.0 | 0 | 1 |
| wallpaper tax | 20.0 | 0 | 1 |
| Wisconsin Department of Revenue | 20.0 | 0 | 1 |
| YouTube Next Lab and Audience Development Group | 20.0 | 0 | 1 |
| Category:Waste management companies of the United States | 20.0 | 0 | 1 |
| Category:Alternative investment management companies | 20.0 | 0 | 1 |
| Category:Apollo Global Management companies | 20.0 | 0 | 1 |
| Category:Cerberus Capital Management companies | 20.0 | 0 | 1 |
| Category:Corporate taxation in the United States | 20.0 | 0 | 1 |
| Category:Corporate taxation in the United Kingdom | 20.0 | 0 | 1 |
| Category:Event management companies | 20.0 | 0 | 1 |
| Category:Investment management companies | 20.0 | 0 | 1 |
| Category:Investment management companies by country | 20.0 | 0 | 1 |
| Category:Investment management companies of Austria | 20.0 | 0 | 1 |
| Category:Investment management companies of Bahrain | 20.0 | 0 | 1 |
| Category:Investment management companies of Belgium | 20.0 | 0 | 1 |
| Category:Investment management companies of Canada | 20.0 | 0 | 1 |
| Category:Investment management companies of Dominica | 20.0 | 0 | 1 |
| Category:Investment management companies of Germany | 20.0 | 0 | 1 |
| Category:Investment management companies of Iceland | 20.0 | 0 | 1 |
| Category:Investment management companies of India | 20.0 | 0 | 1 |
| Category:Investment management companies of Italy | 20.0 | 0 | 1 |
| Category:Investment management companies of Kuwait | 20.0 | 0 | 1 |
| Category:Investment management companies of Liechtenstein | 20.0 | 0 | 1 |
| Category:Investment management companies of Norway | 20.0 | 0 | 1 |
| Category:Investment management companies of South Africa | 20.0 | 0 | 1 |
| Category:Investment management companies of South Korea | 20.0 | 0 | 1 |
| Category:Investment management companies of Switzerland | 20.0 | 0 | 1 |
| Category:Investment management companies of Taiwan | 20.0 | 0 | 1 |
| Category:Investment management companies of Ukraine | 20.0 | 0 | 1 |
| Category:Investment management companies of the Netherlands | 20.0 | 0 | 1 |
| Category:Investment management companies of the United Kingdom | 20.0 | 0 | 1 |
| Category:Investment management companies of the United States | 20.0 | 0 | 1 |
| Category:Japanese voice actor management companies | 20.0 | 0 | 1 |
| Category:Investment management companies of Japan | 20.0 | 0 | 1 |
| Category:Risk management companies | 20.0 | 0 | 1 |
| Category:Pharmacy benefit management companies based in the United States | 20.0 | 0 | 1 |
| Category:Property management companies | 20.0 | 0 | 1 |
| Category:Sports management companies | 20.0 | 0 | 1 |
| Category:Waste management companies of Australia | 20.0 | 0 | 1 |
| Category:Waste management companies of China | 20.0 | 0 | 1 |
| Category:Waste management companies of Pakistan | 20.0 | 0 | 1 |
| Category:Corporate taxation | 20.0 | 0 | 1 |
| Category:Cleaning companies | 20.0 | 0 | 1 |
| Allan Chiang | 20.0 | 0 | 1 |
| Category:Former voice actor management companies | 20.0 | 0 | 1 |
| Category:Waste management companies of France | 20.0 | 0 | 1 |
| Category:Indirect tax | 20.0 | 0 | 1 |
| transfer pricing | 20.0 | 0 | 1 |
| Q10460377 | 20.0 | 0 | 1 |
| local tax office | 20.0 | 0 | 1 |
| China National Agricultural Development Group | 20.0 | 0 | 1 |
| Up Energy Development Group Limited | 20.0 | 0 | 1 |
| Shih Hsing Development Group | 20.0 | 0 | 1 |
| Guangzhou Development Group | 20.0 | 0 | 1 |
| Aceso Life Science Group | 20.0 | 0 | 1 |
| Shenzhen Properties & Resources Development Group | 20.0 | 0 | 1 |
| Condominium Management Companies Association | 20.0 | 0 | 1 |
| Tomoaki Nakao | 20.0 | 0 | 1 |
| Shigeyuki Nakajima | 20.0 | 0 | 1 |
| inhabitants tax | 20.0 | 0 | 1 |
| Takahiko Kodama | 20.0 | 0 | 1 |
| Local Tax Act | 20.0 | 0 | 1 |
| Ryōji Miyauchi | 20.0 | 0 | 1 |
| Tai Yamazaki | 20.0 | 0 | 1 |
| municipal inhabitants tax | 20.0 | 0 | 1 |
| Keisuke Kigawa | 20.0 | 0 | 1 |
| Kinjirō Mori | 20.0 | 0 | 1 |
| Yukito Ishiwari | 20.0 | 0 | 1 |
| Sadajirō Inaguma | 20.0 | 0 | 1 |
| Yayoi Kondō | 20.0 | 0 | 1 |
| prefectural inhabitants tax | 20.0 | 0 | 1 |
| Akira Kurokawa | 20.0 | 0 | 1 |
| State Tax University | 20.0 | 0 | 1 |
| Q13196104 | 20.0 | 0 | 1 |
| Category:Chiefs of Capability Development Group (Australia) | 20.0 | 0 | 1 |
| Category:Waste management companies of Canada | 20.0 | 0 | 1 |
| State Tax Inspectorate of Lithuania | 20.0 | 0 | 1 |
| Category:Waste management companies of the Netherlands | 20.0 | 0 | 1 |
| Vocational Training Council | 20.0 | 0 | 1 |
| Iraq Economic Development Group | 20.0 | 0 | 1 |
| Category:Investment management companies of Pakistan | 20.0 | 0 | 1 |
| Category:Investment management companies of Turkey | 20.0 | 0 | 1 |
| Georg Birnstiel | 20.0 | 0 | 1 |
| Heinrich Breit | 20.0 | 0 | 1 |
| Friedrich Rödler | 20.0 | 0 | 1 |
| Adolf Gerhard Coenenberg | 20.0 | 0 | 1 |
| Lothar Haberstock | 20.0 | 0 | 1 |
| Hubert Fuchs | 20.0 | 0 | 1 |
| Corporate Taxation | 20.0 | 0 | 1 |
| International Tax and Public Finance | 20.0 | 0 | 1 |
| Intertax | 20.0 | 0 | 1 |
| The State and Local Tax Lawyer | 20.0 | 0 | 1 |
| business tax | 20.0 | 0 | 1 |
| Paetz | 20.0 | 0 | 1 |
| Real Estate Transfer Tax | 20.0 | 0 | 1 |
| Q15820285 | 20.0 | 0 | 1 |
| Josef Peter Eggen | 20.0 | 0 | 1 |
| Norbert Jacobs | 20.0 | 0 | 1 |
| Sigrid Brinkmann | 20.0 | 0 | 1 |
| Local Tax Bureau of Taichung City Government | 20.0 | 0 | 1 |
| John J. Studzinski | 20.0 | 0 | 1 |
| David Russell | 20.0 | 0 | 1 |
| Chinese Estates Group | 20.0 | 0 | 1 |
| simplified business tax | 20.0 | 0 | 1 |
| HKND | 20.0 | 0 | 1 |
| Lutz Fischer | 20.0 | 0 | 1 |
| Banking Cash Transaction Tax | 20.0 | 0 | 1 |
| Nanshan Development Group | 20.0 | 0 | 1 |
| Securities Transaction Tax | 20.0 | 0 | 1 |
| investment trust | 20.0 | 0 | 1 |
| Careers Development Group | 20.0 | 0 | 1 |
| Excise tax in the United States | 20.0 | 0 | 1 |
| Ørsted US Offshore Wind | 20.0 | 0 | 1 |
| Patent box regime | 20.0 | 0 | 1 |
| Leonard Development Group | 20.0 | 0 | 1 |
| Magellan Development Group | 20.0 | 0 | 1 |
| Transfer mispricing | 20.0 | 0 | 1 |
| Multistate Tax Commission | 20.0 | 0 | 1 |
| Transfer tax | 20.0 | 0 | 1 |
| Payment in lieu of taxes | 20.0 | 0 | 1 |
| America's Small Business Tax Relief Act of 2014 | 20.0 | 0 | 1 |
| Jūji Komai | 20.0 | 0 | 1 |
| Category:Qatar investment management companies | 20.0 | 0 | 1 |
| Category:Singapore investment management companies | 20.0 | 0 | 1 |
| Category:Investment management companies of Saudi Arabia | 20.0 | 0 | 1 |
| Calls for corporate tax reform in Australia goes unheeded | 20.0 | 0 | 1 |
| Eisaburō Sado | 20.0 | 0 | 1 |
| base erosion and profit shifting | 20.0 | 0 | 1 |
| Peter Kupsch | 20.0 | 0 | 1 |
| corporate taxation | 20.0 | 0 | 1 |
| Sebastian Schanz | 20.0 | 0 | 1 |
| Shinichi Kozu | 20.0 | 0 | 1 |
| Rolf Uwe Fülbier | 20.0 | 0 | 1 |
| The Act Governing Local Tax Regulations | 20.0 | 0 | 1 |
| Value-added and Non-value-added Business Tax Act | 20.0 | 0 | 1 |
| Value-added and non-value-added business tax law | 20.0 | 0 | 1 |
| Kurt Jacob Ball-Kaduri | 20.0 | 0 | 1 |
| First Agricultural National Bank of Berkshire County v. State Tax Commission | 20.0 | 0 | 1 |
| Gorham Manufacturing Company v. State Tax Commission of New Tork | 20.0 | 0 | 1 |
| Warren Trading Post Company v. Arizona State Tax Commission | 20.0 | 0 | 1 |
| State Tax Commission of Utah v. Pacific States Cast Iron Pipe Company | 20.0 | 0 | 1 |
| State Tax on Railway Gross Receipts | 20.0 | 0 | 1 |
| Bass Ratcliff Gretton v. State Tax Commission | 20.0 | 0 | 1 |
| Norfolk & Western Railway Company v. Missouri State Tax Commission | 20.0 | 0 | 1 |
| Joy Oil Company v. State Tax Commission of Michigan | 20.0 | 0 | 1 |
| EAD Tokyo Group No. 2 | 20.0 | 0 | 1 |
| EAD Tokyo Group No. 1 | 20.0 | 0 | 1 |
| Commission on Local Tax Reform | 20.0 | 0 | 1 |
| North Dakota Tax Commissioner | 20.0 | 0 | 1 |
| Lorraine Eden | 20.0 | 0 | 1 |
| Fujian Investment & Development Group Co.,Ltd. | 20.0 | 0 | 1 |
| Project Soul | 20.0 | 0 | 1 |
| Frank Brennan | 20.0 | 0 | 1 |
| aluminium salt exposure | 20.0 | 0 | 1 |
| Versata Development Group, Inc. v. SAP America, Inc. | 20.0 | 0 | 1 |
| Strato-Freight | 20.0 | 0 | 1 |
| Trinity Episcopal Church | 20.0 | 0 | 1 |
| Carlisle Development Group | 20.0 | 0 | 1 |
| G. Brint Ryan | 20.0 | 0 | 1 |
| Diagnosing and managing acute heart failure in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Bermuda Black Hole | 20.0 | 0 | 1 |
| Property Tax Circuit Breaker | 20.0 | 0 | 1 |
| Singapore Sling | 20.0 | 0 | 1 |
| Industrial Development Group - IDG | 20.0 | 0 | 1 |
| JDS Development Group | 20.0 | 0 | 1 |
| Microscale to manufacturing scale‐up of cell‐free cytokine production—a new approach for shortening protein production development timelines | 20.0 | 0 | 1 |
| I Was a Teenage Tax Consultant | 20.0 | 0 | 1 |
| Tax Journal | 20.0 | 0 | 1 |
| Monastic Education Development Group | 20.0 | 0 | 1 |
| taxpayer | 20.0 | 0 | 1 |
| Category:Waste management companies of Denmark | 20.0 | 0 | 1 |
| Category:Corporate tax avoidance | 20.0 | 0 | 1 |
| Category:Waste management companies of Brazil | 20.0 | 0 | 1 |
| Category:Reputation management companies | 20.0 | 0 | 1 |
| Category:Electronic music event management companies | 20.0 | 0 | 1 |
| Category:Investment management companies of Malaysia | 20.0 | 0 | 1 |
| Category:Investment management companies of Haiti | 20.0 | 0 | 1 |
| Property Tax Law (Betterment and Purchase) | 20.0 | 0 | 1 |
| State Tax Service under the Government of the Kyrgyz Republic | 20.0 | 0 | 1 |
| EASTHORPE HOUSE, LOUGHBOROUGH ROAD | 20.0 | 0 | 1 |
| Management of Hyperphosphataemia in Chronic Kidney Disease: Summary of National Institute for Health and Clinical Excellence (NICE) Guideline | 20.0 | 0 | 1 |
| Goods and Services Tax | 20.0 | 0 | 1 |
| Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement | 20.0 | 0 | 1 |
| A protocol to develop clinical guidelines for inclusion-body myositis | 20.0 | 0 | 1 |
| The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting | 20.0 | 0 | 1 |
| OECD Base erosion and profit shifting project | 20.0 | 0 | 1 |
| Bill 28 | 20.0 | 0 | 1 |
| Secondary prevention for patients following a myocardial infarction: summary of NICE guidance | 20.0 | 0 | 1 |
| Canada small business tax rate | 20.0 | 0 | 1 |
| Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations | 20.0 | 0 | 1 |
| Reformulating corporate residence: a coherent response to international tax avoidance | 20.0 | 0 | 1 |
| The politics of implementing e-government for development: the ecology of games shaping property tax administration in Bangalore city, India | 20.0 | 0 | 1 |
| The Effects of Farm Property Tax Relief Programs on Farm Financial Conditions | 20.0 | 0 | 1 |
| Factors affecting property tax reliance: Additional evidence | 20.0 | 0 | 1 |
| Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries | 20.0 | 0 | 1 |
| Viking Development Group (Norway) | 20.0 | 0 | 1 |
| Measured Progress | 20.0 | 0 | 1 |
| Human Resource Development Group | 20.0 | 0 | 1 |
| Physician practice management companies: should physicians be scared? | 20.0 | 0 | 1 |
| Potential role of human challenge studies for investigation of influenza transmission | 20.0 | 0 | 1 |
| Category:Transfer tax | 20.0 | 0 | 1 |
| Category:Financial transaction tax | 20.0 | 0 | 1 |
| Category:Investment management companies of China | 20.0 | 0 | 1 |
| 421-a tax abatement | 20.0 | 0 | 1 |
| Category:Waste management companies of Norway | 20.0 | 0 | 1 |
| Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement | 20.0 | 0 | 1 |
| European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. | 20.0 | 0 | 1 |
| Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors | 20.0 | 0 | 1 |
| Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours | 20.0 | 0 | 1 |
| Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure | 20.0 | 0 | 1 |
| Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data | 20.0 | 0 | 1 |
| Private long-term care insurance and state tax incentives | 20.0 | 0 | 1 |
| Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group | 20.0 | 0 | 1 |
| Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development | 20.0 | 0 | 1 |
| The value and impact of information provided through library services for patient care: developing guidance for best practice | 20.0 | 0 | 1 |
| The need to develop transfer pricing methods grows as systems become regional | 20.0 | 0 | 1 |
| Physician practice management companies: implications for hospital-based integrated delivery systems | 20.0 | 0 | 1 |
| Pharmacy benefit management companies (PBMs). Why should we be interested? | 20.0 | 0 | 1 |
| Property tax exemption for nonprofit hospitals | 20.0 | 0 | 1 |
| Utah County v. Intermountain Health Care: Utah's unique method for determining charitable property tax exemptions--a review of its mandate and impact | 20.0 | 0 | 1 |
| Pharmacy benefit management companies: dimensions of performance | 20.0 | 0 | 1 |
| Growth of oncology physician practice management companies | 20.0 | 0 | 1 |
| Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group | 20.0 | 0 | 1 |
| Adult day health care evaluation study: methodology and implementation. Adult Day Health Care Evaluation Development Group. | 20.0 | 0 | 1 |
| Workplace management of upper limb disorders: a systematic review | 20.0 | 0 | 1 |
| North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group | 20.0 | 0 | 1 |
| Guidelines for the prevention of falls in people over 65. The Guidelines' Development Group | 20.0 | 0 | 1 |
| Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits1 | 20.0 | 0 | 1 |
| Managing chronic pain in the non-specialist setting: a new SIGN guideline | 20.0 | 0 | 1 |
| Interventions to address sexual problems in people with cancer | 20.0 | 0 | 1 |
| Tax Compliance Inventory: TAX-I Voluntary tax compliance, enforced tax compliance, tax avoidance, and tax evasion | 20.0 | 0 | 1 |
| Framing of information on the use of public finances, regulatory fit of recipients and tax compliance. | 20.0 | 0 | 1 |
| Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809. | 20.0 | 0 | 1 |
| FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable li | 20.0 | 0 | 1 |
| Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology | 20.0 | 0 | 1 |
| Computerized Prescriber Order Entry in the Outpatient Oncology Setting: From Evidence to Meaningful Use | 20.0 | 0 | 1 |
| NICE clinical guideline: chest pain of recent onset | 20.0 | 0 | 1 |
| Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Regulatory fit effects on perceived fiscal exchange and tax compliance. | 20.0 | 0 | 1 |
| Canadian Headache Society guideline for migraine prophylaxis. | 20.0 | 0 | 1 |
| Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance | 20.0 | 0 | 1 |
| State tax incentives for person giving informal care of the elderly | 20.0 | 0 | 1 |
| Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance | 20.0 | 0 | 1 |
| Canadian Headache Society Guideline: acute drug therapy for migraine headache | 20.0 | 0 | 1 |
| Biomarker tests for the diagnosis of Alzheimer's disease: Generating evidence to inform insurance coverage determinations | 20.0 | 0 | 1 |
| Clinical practice guideline on diagnosis and treatment of hyponatraemia. | 20.0 | 0 | 1 |
| Transfer pricing in hospitals and efficiency of physicians: the case of anesthesia services | 20.0 | 0 | 1 |
| Epoetin alfa in cancer patients: evidence-based guidelines | 20.0 | 0 | 1 |
| Clinical practice guideline: Allergic rhinitis | 20.0 | 0 | 1 |
| Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance | 20.0 | 0 | 1 |
| BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults | 20.0 | 0 | 1 |
| Management companies: Revenue Canada reveals its audit policy. | 20.0 | 0 | 1 |
| Exercise-based cardiac rehabilitation in patients with chronic heart failure: a Dutch practice guideline | 20.0 | 0 | 1 |
| The business transfer tax: it could affect your practice | 20.0 | 0 | 1 |
| Maternal and infantile dietary salt exposure may cause hypertension later in life | 20.0 | 0 | 1 |
| The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline | 20.0 | 0 | 1 |
| PROCEDURAL FAIRNESS AND TAX COMPLIANCE. | 20.0 | 0 | 1 |
| Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of acute gastrointestinal blood loss: summary of SIGN guidelines | 20.0 | 0 | 1 |
| Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines | 20.0 | 0 | 1 |
| Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatment | 20.0 | 0 | 1 |
| Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. | 20.0 | 0 | 1 |
| What should you consider in your last-minute tax planning? | 20.0 | 0 | 1 |
| British Thoracic Society guidelines for the management of suspected acute pulmonary embolism | 20.0 | 0 | 1 |
| Optimisation of preoperative assessment in patients diagnosed with rectal cancer. | 20.0 | 0 | 1 |
| Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group | 20.0 | 0 | 1 |
| Management of generalised anxiety disorder in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| When to suspect child maltreatment: summary of NICE guidance | 20.0 | 0 | 1 |
| A multi-centre, randomised controlled trial of the effectiveness of PDSAFE to prevent falls among people with Parkinson's: study protocol | 20.0 | 0 | 1 |
| Examining the value of pharmacy benefit management companies. | 20.0 | 0 | 1 |
| Enhancing Tax Compliance through Coercive and Legitimate Power of Tax Authorities by Concurrently Diminishing or Facilitating Trust in Tax Authorities | 20.0 | 0 | 1 |
| Management of rheumatoid arthritis: summary of NICE guidance. | 20.0 | 0 | 1 |
| Diagnosis and treatment of advanced breast cancer: summary of NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and treatment of early breast cancer, including locally advanced disease--summary of NICE guidance | 20.0 | 0 | 1 |
| Effectiveness of Nonpharmacologic Interventions for Decreasing Fatigue in Adults With Systemic Lupus Erythematosus: A Systematic Review | 20.0 | 0 | 1 |
| Identification, diagnosis and assessment of atrial fibrillation | 20.0 | 0 | 1 |
| Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting | 20.0 | 0 | 1 |
| Rhythm control and cardioversion | 20.0 | 0 | 1 |
| Patient care pathway, implementation and audit criteria for patients with atrial fibrillation | 20.0 | 0 | 1 |
| Rate control in the medical management of atrial fibrillation | 20.0 | 0 | 1 |
| Revenue Canada plans new attack on management companies | 20.0 | 0 | 1 |
| Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline | 20.0 | 0 | 1 |
| Assessment and initial management of feverish illness in children younger than 5 years: summary of NICE guidance | 20.0 | 0 | 1 |
| Preconditions of Voluntary Tax Compliance: Knowledge and Evaluation of Taxation, Norms, Fairness, and Motivation to Cooperate | 20.0 | 0 | 1 |
| Management of faecal incontinence in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Recognising and responding to acute illness in adults in hospital: summary of NICE guidance | 20.0 | 0 | 1 |
| "Willing to Pay?" Tax Compliance in Britain and Italy: An Experimental Analysis | 20.0 | 0 | 1 |
| Champaign County, Illinois, gets hospital industry's attention by revoking property tax exemption of local catholic hospital [interviewed by Stan Jenkins]. | 20.0 | 0 | 1 |
| A multidisciplinary evidence-based guideline for minimally invasive surgery.: Part 1: entry techniques and the pneumoperitoneum | 20.0 | 0 | 1 |
| Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. | 20.0 | 0 | 1 |
| Use of antidepressant medication following acquired brain injury: concise guidance. | 20.0 | 0 | 1 |
| Are you entitled to a real property tax rebate? | 20.0 | 0 | 1 |
| Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline | 20.0 | 0 | 1 |
| Management of atopic eczema in children aged up to 12 years: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of cervical cancer: summary of SIGN guidelines | 20.0 | 0 | 1 |
| Gastro-oesophageal reflux disease in children: NICE guidance | 20.0 | 0 | 1 |
| Intrapartum care of healthy women and their babies: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Care and management of osteoarthritis in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and treatment of prostate cancer: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of diabetes from preconception to the postnatal period: summary of NICE guidance | 20.0 | 0 | 1 |
| Prophylaxis against infective endocarditis: summary of NICE guidance. | 20.0 | 0 | 1 |
| North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults | 20.0 | 0 | 1 |
| Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research | 20.0 | 0 | 1 |
| The Royal College of Ophthalmologists' Cataract Surgery Commissioning Guidance: executive summary | 20.0 | 0 | 1 |
| Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of type 2 diabetes: summary of updated NICE guidance. | 20.0 | 0 | 1 |
| Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis | 20.0 | 0 | 1 |
| The impact of a financial transaction tax on stylized facts of price returns-Evidence from the lab. | 20.0 | 0 | 1 |
| Delirium: guidelines for general hospitals. | 20.0 | 0 | 1 |
| Are Some Countries More Honest than Others? Evidence from a Tax Compliance Experiment in Sweden and Italy | 20.0 | 0 | 1 |
| Pregnancy: occupational aspects of management: concise guidance | 20.0 | 0 | 1 |
| Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review | 20.0 | 0 | 1 |
| Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group | 20.0 | 0 | 1 |
| Pharmacological management of hypertension. | 20.0 | 0 | 1 |
| Clinical practice guideline for cardiovascular risk management in the Netherlands. | 20.0 | 0 | 1 |
| Use a stepped approach for atopic eczemia in children | 20.0 | 0 | 1 |
| Guideline for management of postmeal glucose | 20.0 | 0 | 1 |
| De novo transcriptome assembly and analysis of differentially expressed genes of two barley genotypes reveal root-zone-specific responses to salt exposure | 20.0 | 0 | 1 |
| Exercise-based cardiac rehabilitation in patients with coronary heart disease: a practice guideline. | 20.0 | 0 | 1 |
| Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis | 20.0 | 0 | 1 |
| Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project | 20.0 | 0 | 1 |
| Publication guidelines for quality improvement in health care: evolution of the SQUIRE project | 20.0 | 0 | 1 |
| Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project | 20.0 | 0 | 1 |
| Traveller's thrombosis: international consensus statement | 20.0 | 0 | 1 |
| Identification and management of familial hypercholesterolaemia: what does it mean to primary care? | 20.0 | 0 | 1 |
| International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities | 20.0 | 0 | 1 |
| Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project | 20.0 | 0 | 1 |
| Toward a consensus on the QALY. | 20.0 | 0 | 1 |
| Patriotism's Impact on Cooperation with the State: An Experimental Study on Tax Compliance | 20.0 | 0 | 1 |
| Unspecific binding of cRNA probe to plaques in two mouse models for Alzheimer's disease. | 20.0 | 0 | 1 |
| Primary Care Patients' Willingness to Participate in Comprehensive Weight Loss Programs: From the WWAMI Region Practice and Research Network | 20.0 | 0 | 1 |
| An appraisal of drug development timelines in the Era of precision oncology | 20.0 | 0 | 1 |
| Exercise for people with cancer: a clinical practice guideline | 20.0 | 0 | 1 |
| Evidence‐based guidelines for the prevention, identification and management of occupational contact dermatitis and urticaria* | 20.0 | 0 | 1 |
| Consensus recommendations for the management of constipation in patients with advanced, progressive illness | 20.0 | 0 | 1 |
| Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany | 20.0 | 0 | 1 |
| 2013 UK National Guideline for the management of lymphogranuloma venereum: Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG/BASHH) Guideline development group | 20.0 | 0 | 1 |
| Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy | 20.0 | 0 | 1 |
| Synopsis of the National Institute for Health and Clinical Excellence Guideline for Prevention of Delirium | 20.0 | 0 | 1 |
| Management of occupational dermatitis in healthcare workers: a systematic review: Figure 1 | 20.0 | 0 | 1 |
| Donor identification and consent for deceased organ donation: summary of NICE guidance | 20.0 | 0 | 1 |
| Complex regional pain syndrome in adults: concise guidance. | 20.0 | 0 | 1 |
| Management of an acute painful sickle cell episode in hospital: summary of NICE guidance | 20.0 | 0 | 1 |
| Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance | 20.0 | 0 | 1 |
| Assessment and management of psoriasis: summary of NICE guidance | 20.0 | 0 | 1 |
| Key recommendations and evidence from the NICE guideline for the acute management of ST-segment-elevation myocardial infarction. | 20.0 | 0 | 1 |
| Screening High-Risk Populations for Lung Cancer: Guideline Recommendations | 20.0 | 0 | 1 |
| Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? | 20.0 | 0 | 1 |
| Spanish consensus on the physical health of patients with depressive disorders | 20.0 | 0 | 1 |
| Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence | 20.0 | 0 | 1 |
| Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis | 20.0 | 0 | 1 |
| A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. | 20.0 | 0 | 1 |
| Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin | 20.0 | 0 | 1 |
| Cardiovascular disease risk in women with a history of spontaneous preterm delivery: A systematic review and meta-analysis | 20.0 | 0 | 1 |
| Implementation of an internal transfer pricing system for anaesthesia services | 20.0 | 0 | 1 |
| Perceived Distributive Fairness of EU Transfer Payments, Outcome Favorability, Identity, and EU-Tax Compliance. | 20.0 | 0 | 1 |
| Outside information. Annual survey shows contract-management companies post strong revenue gains as providers continue to seek their expertise. | 20.0 | 0 | 1 |
| Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. | 20.0 | 0 | 1 |
| The British Thoracic Society guidelines on the investigation and management of pulmonary nodules | 20.0 | 0 | 1 |
| Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. | 20.0 | 0 | 1 |
| NICE-Accredited Commissioning Guidance for Weight Assessment and Management Clinics: a Model for a Specialist Multidisciplinary Team Approach for People with Severe Obesity | 20.0 | 0 | 1 |
| Change detection using Landsat images and an analysis of the linkages between the change and property tax values in the Istanbul Province of Turkey | 20.0 | 0 | 1 |
| Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society | 20.0 | 0 | 1 |
| The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking | 20.0 | 0 | 1 |
| New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. | 20.0 | 0 | 1 |
| The 2014 International Pressure Ulcer Guideline: methods and development | 20.0 | 0 | 1 |
| Development of the SQUIRE Publication Guidelines: evolution of the SQUIRE project | 20.0 | 0 | 1 |
| Diffusion of the property tax work-off program for senior homeowners in Massachusetts | 20.0 | 0 | 1 |
| Distributive justice and global health: a call for a global corporate tax. | 20.0 | 0 | 1 |
| Research ethics committee decision-making in relation to an efficient neonatal trial. | 20.0 | 0 | 1 |
| Physician practice management companies may offer relief | 20.0 | 0 | 1 |
| Proteomic and Transcriptional Analysis of Lactobacillus johnsonii PF01 during Bile Salt Exposure by iTRAQ Shotgun Proteomics and Quantitative RT-PCR | 20.0 | 0 | 1 |
| Radiologists' preferences for digital mammographic display. The International Digital Mammography Development Group | 20.0 | 0 | 1 |
| Policy Implications of Property Tax Relief for the Elderly | 20.0 | 0 | 1 |
| Court decision offers corporate tax relief. | 20.0 | 0 | 1 |
| Experienced clinical educators improve their clinical teaching effectiveness | 20.0 | 0 | 1 |
| Hospital management companies see rapid growth in international market | 20.0 | 0 | 1 |
| Tax planning for dentists: a review of recent proposals | 20.0 | 0 | 1 |
| Prevention and treatment of surgical site infection: summary of NICE guidance | 20.0 | 0 | 1 |
| The future of property tax exemption for nonprofit health care organizations | 20.0 | 0 | 1 |
| State taxes: legislature fine-tunes revised franchise tax; allocates additional funding for future property tax cuts. | 20.0 | 0 | 1 |
| Assessment and initial management of feverish illness in children younger than 5 years: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line | 20.0 | 0 | 1 |
| Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression | 20.0 | 0 | 1 |
| New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. | 20.0 | 0 | 1 |
| Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line | 20.0 | 0 | 1 |
| Suspected sepsis: summary of NICE guidance | 20.0 | 0 | 1 |
| Capital transfer tax. | 20.0 | 0 | 1 |
| Tuberculosis--diagnosis, management, prevention, and control: summary of updated NICE guidance | 20.0 | 0 | 1 |
| The case for physician practice management companies. And why they haven't taken hold in Minnesota | 20.0 | 0 | 1 |
| Public physician practice management companies. Present issues and recommendations for future viability. | 20.0 | 0 | 1 |
| Physician Practice Management Companies | 20.0 | 0 | 1 |
| The future of physician practice management companies. | 20.0 | 0 | 1 |
| Pharmacy benefit management companies. | 20.0 | 0 | 1 |
| Transfer pricing--better decisions for greater savings | 20.0 | 0 | 1 |
| World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health Approach | 20.0 | 0 | 1 |
| Evaluation of the aetiological role of dietary salt exposure in gastric and other cancers in humans | 20.0 | 0 | 1 |
| Exercise for people with cancer: a systematic review | 20.0 | 0 | 1 |
| Special report on taxation. Is your property tax exemption subject to challenge? | 20.0 | 0 | 1 |
| Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Interrenal tissue reaction of the hypophysectomized sexually mature sterlet (Acipenser ruthenus L.) to salt exposure | 20.0 | 0 | 1 |
| Capital acquisition planning in a managed-care environment | 20.0 | 0 | 1 |
| Managing an automation development group | 20.0 | 0 | 1 |
| Antithrombotic treatment in atrial fibrillation | 20.0 | 0 | 1 |
| Year end tax planning. | 20.0 | 0 | 1 |
| Assessment and referral after emergency treatment of a suspected anaphylactic episode: summary of NICE guidance | 20.0 | 0 | 1 |
| Commissioning guidance for weight assessment and management in adults and children with severe complex obesity. | 20.0 | 0 | 1 |
| Physician practice management companies: a failed concept | 20.0 | 0 | 1 |
| Materials for Rural Housing: the Building Materials Work of the Intermediate Technology Development Group | 20.0 | 0 | 1 |
| The role of the automation development group in analytical research and development at Dupont Merck | 20.0 | 0 | 1 |
| Emergency treatment of anaphylaxis in adults: concise guidance. | 20.0 | 0 | 1 |
| Income splitting--a facet of tax planning. | 20.0 | 0 | 1 |
| Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. | 20.0 | 0 | 1 |
| The roles of a process development group in biopharmaceutical process startup | 20.0 | 0 | 1 |
| Rule against foreign revenue enforcement | 20.0 | 0 | 1 |
| Attiya Waris | 20.0 | 0 | 1 |
| Effects of supervision on tax compliance: Evidence from a field experiment in Austria | 20.0 | 0 | 1 |
| Optimizing z-axis coverage of abdominal CT scans of the urinary tract: a proposed alternative proximal landmark for acquisition planning | 20.0 | 0 | 1 |
| Atrial fibrillation: Rate control and digoxin | 20.0 | 0 | 1 |
| Is your tax advisor doing his job? | 20.0 | 0 | 1 |
| Concise guidance: diagnosis and management of giant cell arteritis | 20.0 | 0 | 1 |
| New federal legislation on corporate tax rates to be opposed by CMA | 20.0 | 0 | 1 |
| Year end tax planning. | 20.0 | 0 | 1 |
| Diagnosis and clinical management of alcohol related physical complications: summary of NICE guidance | 20.0 | 0 | 1 |
| Short-term effects of salt exposure on the maize chloroplast protein pattern | 20.0 | 0 | 1 |
| A model to minimize joint total costs for industrial waste producers and waste management companies | 20.0 | 0 | 1 |
| The multiple market-exposure of waste management companies: a case study of two Swedish municipally owned companies | 20.0 | 0 | 1 |
| Common tax planning mistakes | 20.0 | 0 | 1 |
| Diagnosis and management of varicose veins in the legs: summary of NICE guidance | 20.0 | 0 | 1 |
| Letter: Capital transfer tax. | 20.0 | 0 | 1 |
| Year-end tax planning. | 20.0 | 0 | 1 |
| Act on Management Companies and Investment Funds | 20.0 | 0 | 1 |
| Medicaid expansion's tax implications. Opponents should consider fairest way to pay for healthcare | 20.0 | 0 | 1 |
| Capital transfer tax | 20.0 | 0 | 1 |
| Assistance of tax advisors in business and liquidation problems in dental practice | 20.0 | 0 | 1 |
| Financial success may invite local tax scrutiny | 20.0 | 0 | 1 |
| Teachers Development Group | 20.0 | 0 | 1 |
| The influence of short-term anion salt exposure on urine pH and on resistance to experimentally induced hypocalcaemia in cows | 20.0 | 0 | 1 |
| Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance | 20.0 | 0 | 1 |
| Comparison of the efficacy and safety of nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma. | 20.0 | 0 | 1 |
| Use of the management company in tax planning | 20.0 | 0 | 1 |
| Understand tax implications of practice buy-ins, buy-outs. | 20.0 | 0 | 1 |
| Impact of the Level of State Tax Code Progressivity on Children's Health Outcomes | 20.0 | 0 | 1 |
| Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group | 20.0 | 0 | 1 |
| Recognition, intervention, and management of antisocial behaviour and conduct disorders in children and young people: summary of NICE-SCIE guidance | 20.0 | 0 | 1 |
| Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease | 20.0 | 0 | 1 |
| RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group | 20.0 | 0 | 1 |
| Inclusion of urine analysis not justified | 20.0 | 0 | 1 |
| Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study | 20.0 | 0 | 1 |
| Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning | 20.0 | 0 | 1 |
| A somewhat unorthodox explanation for the rise and fall of physician practice management companies: the application of Gaia theory | 20.0 | 0 | 1 |
| Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative | 20.0 | 0 | 1 |
| Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance | 20.0 | 0 | 1 |
| Rehabilitation after stroke: summary of NICE guidance | 20.0 | 0 | 1 |
| Market versus Residence Principle: Experimental Evidence on the Effects of a Financial Transaction Tax. | 20.0 | 0 | 1 |
| Buy-Sell Agreements: Tax Implications | 20.0 | 0 | 1 |
| Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and initial management of transient ischaemic attack | 20.0 | 0 | 1 |
| Tax planning may be best way for MDs to minimize GST's impact | 20.0 | 0 | 1 |
| Acute kidney injury: summary of NICE guidance | 20.0 | 0 | 1 |
| Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance | 20.0 | 0 | 1 |
| British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE | 20.0 | 0 | 1 |
| Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia | 20.0 | 0 | 1 |
| Winners and losers. Corporate tax overhaul would have very different effects for various healthcare sectors | 20.0 | 0 | 1 |
| The child development group of Mississippi: A hot sector of the quiet front in the war on poverty | 20.0 | 0 | 1 |
| Diagnosis and initial management of acute stroke and transient ischaemic attack: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of hypertension: summary of NICE guidance | 20.0 | 0 | 1 |
| The impact of high-salt exposure on cardiovascular development in the early chick embryo | 20.0 | 0 | 1 |
| Surviving in a semi-marine habitat: Dietary salt exposure and salt secretion of a New Zealand intertidal skink | 20.0 | 0 | 1 |
| Problem alcohol use among problem drug users: development and content of clinical guidelines for general practice | 20.0 | 0 | 1 |
| Diagnosis and management of idiopathic childhood constipation: summary of NICE guidance | 20.0 | 0 | 1 |
| Single Property Tax | 20.0 | 0 | 1 |
| becon number | 20.0 | 0 | 1 |
| Management of hip fracture in adults: summary of NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and management of menopause: summary of NICE guidance | 20.0 | 0 | 1 |
| How many infective viral particles are necessary for successful mass measles immunization by aerosol? | 20.0 | 0 | 1 |
| Diagnosis and Management of Menopause: The National Institute of Health and Care Excellence (NICE) Guideline | 20.0 | 0 | 1 |
| Evidence- and Consensus-Based Guidelines for the Management of Communication and Swallowing Disorders Following Pediatric Traumatic Brain Injury | 20.0 | 0 | 1 |
| NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations | 20.0 | 0 | 1 |
| BTS guideline for oxygen use in adults in healthcare and emergency settings | 20.0 | 0 | 1 |
| Developing learning outcomes for medical students and foundation doctors in palliative care: a national consensus-seeking initiative in Scotland | 20.0 | 0 | 1 |
| Managing chronic pain: a clinical challenge: new SIGN guidelines provide a practical evidence-based approach and identify research gaps. | 20.0 | 0 | 1 |
| Label-free quantitative proteomic analysis of Lactobacillus fermentum NCDC 400 during bile salt exposure | 20.0 | 0 | 1 |
| British Thoracic Society guidelines for home oxygen use in adults | 20.0 | 0 | 1 |
| Hyponatraemia diagnosis and treatment clinical practice guidelines | 20.0 | 0 | 1 |
| Challenging behaviour and learning disabilities: summary of NICE guidance | 20.0 | 0 | 1 |
| How and why do we do testicular ultrasounds? A national clinical development group survey of genitourinary medicine clinics. | 20.0 | 0 | 1 |
| World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals | 20.0 | 0 | 1 |
| fMRI for vegetative and minimally conscious states | 20.0 | 0 | 1 |
| BTS guidelines for home oxygen in children | 20.0 | 0 | 1 |
| Polarization-basis tracking scheme for quantum key distribution using revealed sifted key bits | 20.0 | 0 | 1 |
| Teaching acute care: a course for undergraduates | 20.0 | 0 | 1 |
| The impact of outcome orientation and justice concerns on tax compliance: the role of taxpayers' identity. | 20.0 | 0 | 1 |
| Shichirō Karino | 20.0 | 0 | 1 |
| Frenzy surrounds practice management companies. | 20.0 | 0 | 1 |
| Longer term management of self harm: summary of NICE guidance | 20.0 | 0 | 1 |
| Gaming of performance measurement in health care: parallels with tax compliance | 20.0 | 0 | 1 |
| Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of Chronic Heart Failure in Adults: Synopsis of the National Institute for Health and Clinical Excellence Guideline | 20.0 | 0 | 1 |
| The international pressure ulcer guideline development group response to pressure ulcer risk assessment: do we need a golden hour? | 20.0 | 0 | 1 |
| Introduction to special section on using pools to generate Good Laboratory Practice tox or other non-clinical material to accelerate development timelines | 20.0 | 0 | 1 |
| Accelerating clinical development timelines | 20.0 | 0 | 1 |
| ACCCN Workforce Standards for Intensive Care Nursing: Systematic and evidence review, development, and appraisal. | 20.0 | 0 | 1 |
| Composition of Canadian Pain Society guideline development group? | 20.0 | 0 | 1 |
| Begin year-end tax planning with a look at vehicle purchases | 20.0 | 0 | 1 |
| Diagnosis and management of gallstone disease: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of type 2 diabetes in adults: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Management of autism in children and young people: summary of NICE and SCIE guidance | 20.0 | 0 | 1 |
| Early management of head injury: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Improving the experience of care for adults using NHS mental health services: summary of NICE guidance | 20.0 | 0 | 1 |
| Management of hypertensive disorders during pregnancy: summary of NICE guidance | 20.0 | 0 | 1 |
| Practical Action | 20.0 | 0 | 1 |
| Antenatal and postnatal mental health: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Assessment and management of bipolar disorder: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Tax planning strategies for physicians | 20.0 | 0 | 1 |
| Property tax and inter-municipal migration in Canada: a multivariate test of the Tiebout hypothesis | 20.0 | 0 | 1 |
| Prevention, detection and management of acute kidney injury: concise guideline | 20.0 | 0 | 1 |
| A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial | 20.0 | 0 | 1 |
| Identification and care pathways for common mental health disorders: summary of NICE guidance | 20.0 | 0 | 1 |
| Intravenous fluid therapy for adults in hospital: summary of NICE guidance | 20.0 | 0 | 1 |
| Reduction of anesthesia process times after the introduction of an internal transfer pricing system for anesthesia services | 20.0 | 0 | 1 |
| Response to Comment on 'epic3: revised recommendation for intravenous catheter and catheter site care'. | 20.0 | 0 | 1 |
| Assessment and initial management of major trauma: summary of NICE guidance | 20.0 | 0 | 1 |
| Sedation for diagnostic and therapeutic procedures in children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Water quality monitoring programs | 20.0 | 0 | 1 |
| Forest taxation | 20.0 | 0 | 1 |
| Pulmonary nodules again? The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules. | 20.0 | 0 | 1 |
| British Thoracic Society guidelines for the investigation and management of pulmonary nodules. | 20.0 | 0 | 1 |
| Bronchiolitis in children: summary of NICE guidance | 20.0 | 0 | 1 |
| Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance | 20.0 | 0 | 1 |
| Advanced breast cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence Guideline 2009 - a solid basis for good clinical practice | 20.0 | 0 | 1 |
| Pulmonary metastasectomy in colorectal cancer: time for a trial | 20.0 | 0 | 1 |
| New guidelines for the management of migraine in primary care | 20.0 | 0 | 1 |
| Becoming emotionally and experientially available: a staff development group in a multidisciplinary university clinic | 20.0 | 0 | 1 |
| Utilization of a staff development group in prison consultation | 20.0 | 0 | 1 |
| Medicare managed care: budgetary and tax implications | 20.0 | 0 | 1 |
| Feargal O'Rourke | 20.0 | 0 | 1 |
| Tax compliance and reporting | 20.0 | 0 | 1 |
| Melanoma: summary of NICE guidance | 20.0 | 0 | 1 |
| The management of atrial fibrillation: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance | 20.0 | 0 | 1 |
| Beijing Urban Construction Design & Development Group Co., Ltd. | 20.0 | 0 | 1 |
| Compressing drug development timelines in oncology using phase '0' trials | 20.0 | 0 | 1 |
| Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) | 20.0 | 0 | 1 |
| Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System? | 20.0 | 0 | 1 |
| Intravenous fluids in children and young people: summary of NICE guidance | 20.0 | 0 | 1 |
| Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance | 20.0 | 0 | 1 |
| Early clinical trials in paediatric oncology in Spain: a nationwide perspective | 20.0 | 0 | 1 |
| Tax planning. What every woman should know about her husband's will. I | 20.0 | 0 | 1 |
| P.Z.Karen Co. Development Group | 20.0 | 0 | 1 |
| Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance | 20.0 | 0 | 1 |
| PPMCs (physician practice management companies). What happens when doctors flock together. | 20.0 | 0 | 1 |
| Assessment and management of cirrhosis in people older than 16 years: summary of NICE guidance. | 20.0 | 0 | 1 |
| The Royal College of Ophthalmologists' Glaucoma Commissioning Guidance: executive summary | 20.0 | 0 | 1 |
| Management companies: an update | 20.0 | 0 | 1 |
| Financing Urban Development in Mexico City: A Case Study of Property Tax, Land Use, Housing, and Urban Planning | 20.0 | 0 | 1 |
| Property tax exemptions: headed for extinction? | 20.0 | 0 | 1 |
| Matheson | 20.0 | 0 | 1 |
| Conduit and Sink OFCs | 20.0 | 0 | 1 |
| Sunny Canadian Development Group | 20.0 | 0 | 1 |
| Ireland as a tax haven | 20.0 | 0 | 1 |
| Benton Development Group | 20.0 | 0 | 1 |
| Management of rhinosinusitis in adults in primary care | 20.0 | 0 | 1 |
| Australian corporate tax rate | 20.0 | 0 | 1 |
| Q55758450 | 20.0 | 0 | 1 |
| Long‐Run Corporate Tax Avoidance | 20.0 | 0 | 1 |
| Category:Waste management companies of Finland | 20.0 | 0 | 1 |
| The Changing Property Tax and State-Local Relations | 20.0 | 0 | 1 |
| The effect of a transaction tax on exchange rate volatility | 20.0 | 0 | 1 |
| The effects of the stock transaction tax on the stock market – Experiences from Asian markets | 20.0 | 0 | 1 |
| Estimating Employment Spillover Effects In New York City with an Application to The Stock Transfer Tax | 20.0 | 0 | 1 |
| OECD Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations 2010 | 20.0 | 0 | 1 |
| Aligning Transfer Pricing Outcomes with Value Creation, Actions 8-10 - 2015 Final Reports | 20.0 | 0 | 1 |
| Tax compliance and obedience to authority at home and in the lab: A new experimental approach | 20.0 | 0 | 1 |
| The Unintended Consequences of Bilateralism: Treaty Shopping and International Tax Policy | 20.0 | 0 | 1 |
| Jessie Javier Carlos | 20.0 | 0 | 1 |
| Write Now! | 20.0 | 0 | 1 |
| Property Tax Assessment Rates and Residential Abandonment | 20.0 | 0 | 1 |
| The assessment of pain in older people | 20.0 | 0 | 1 |
| Diagnosis, prevention, and management of delirium: summary of NICE guidance | 20.0 | 0 | 1 |
| Ursa Labs | 20.0 | 0 | 1 |
| Fiscal exchange, collective decision institutions, and tax compliance | 20.0 | 0 | 1 |
| Indirect Tax Laws Amendment (Assessment) Act 2012 | 20.0 | 0 | 1 |
| Tax Laws Amendment (Cross-Border Transfer Pricing) Act (No. 1) 2012 | 20.0 | 0 | 1 |
| New Business Tax System (Integrity and Other Measures) Act 1999 | 20.0 | 0 | 1 |
| A New Tax System (Indirect Tax and Consequential Amendments) Act 1999 | 20.0 | 0 | 1 |
| A New Tax System (Indirect Tax and Consequential Amendments) Act (No. 2) 1999 | 20.0 | 0 | 1 |
| A New Tax System (Indirect Tax Administration) Act 1999 | 20.0 | 0 | 1 |
| New Business Tax System (Income Tax Rates) Act (No. 2) 1999 | 20.0 | 0 | 1 |
| New Business Tax System (Alienated Personal Services Income) Tax Imposition Act (No. 1) 2000 | 20.0 | 0 | 1 |
| New Business Tax System (Alienated Personal Services Income) Tax Imposition Act (No. 2) 2000 | 20.0 | 0 | 1 |
| New Business Tax System (Integrity Measures) Act 2000 | 20.0 | 0 | 1 |
| New Business Tax System (Alienation of Personal Services Income) Act 2000 | 20.0 | 0 | 1 |
| New Business Tax System (Capital Allowances) Act 2001 | 20.0 | 0 | 1 |
| New Business Tax System (Simplified Tax System) Act 2001 | 20.0 | 0 | 1 |
| New Business Tax System (Over-franking Tax) Act 2002 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2002 | 20.0 | 0 | 1 |
| New Business Tax System (Imputation) Act 2002 | 20.0 | 0 | 1 |
| New Business Tax System (Franking Deficit Tax) Amendment Act 2002 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 2) 2002 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act 2003 | 20.0 | 0 | 1 |
| New International Tax Arrangements Act 2004 | 20.0 | 0 | 1 |
| New Business Tax System (Franking Deficit Tax) Act 2002 | 20.0 | 0 | 1 |
| New International Tax Arrangements (Managed Funds and Other Measures) Act 2005 | 20.0 | 0 | 1 |
| New International Tax Arrangements (Foreign-owned Branches and Other Measures) Act 2005 | 20.0 | 0 | 1 |
| New International Tax Arrangements (Participation Exemption and Other Measures) Act 2004 | 20.0 | 0 | 1 |
| New Business Tax System (Untainting Tax) Act 2006 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2006 | 20.0 | 0 | 1 |
| New Business Tax System (Debt and Equity) Act 2001 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2007 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 2) 2007 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2008 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 2) 2008 | 20.0 | 0 | 1 |
| Tax Laws Amendment (Small Business and General Business Tax Break) Act 2009 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2009 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2010 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 2) 2010 | 20.0 | 0 | 1 |
| New Business Tax System (Consolidation and Other Measures) Act 2003 | 20.0 | 0 | 1 |
| New Business Tax System (Consolidation and Other Measures) Act (No. 1) 2002 | 20.0 | 0 | 1 |
| New Business Tax System (Taxation of Financial Arrangements) Act (No. 1) 2003 | 20.0 | 0 | 1 |
| New Business Tax System (Capital Gains Tax) Act 1999 | 20.0 | 0 | 1 |
| New Business Tax System (Miscellaneous) Act (No. 2) 2000 | 20.0 | 0 | 1 |
| New Business Tax System (Miscellaneous) Act (No. 1) 2000 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act (No. 1) 2011 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act 2013 | 20.0 | 0 | 1 |
| New Business Tax System (Former Subsidiary Tax Imposition) Act 1999 | 20.0 | 0 | 1 |
| New Business Tax System (Venture Capital Deficit Tax) Act 2003 | 20.0 | 0 | 1 |
| International Tax Agreements Amendment Act 2014 | 20.0 | 0 | 1 |
| New Business Tax System (Consolidation, Value Shifting, Demergers and Other Measures) Act 2002 | 20.0 | 0 | 1 |